Ernexa Therapeutics Inc. Warrants (ERNAW) Financials

ERNAW Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 10.5 million 3.7 million
Dec. 31, 2025 5.8 million 3.4 million
Sept. 30, 2025 6.2 million 2.6 million
June 30, 2025 7.6 million 3.1 million

ERNAW Free Cash Flow and Stock based compensation

No data available :(

ERNAW Net Income

No data available :(

ERNAW Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 9.2 million - 226000
Dec. 31, 2025 1.9 million - 277000
Sept. 30, 2025 3.0 million - 346000
June 30, 2025 4.3 million - 376000

ERNAW Shares Outstanding

No data available :(

ERNAW Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2000 1.9 million 1.5 million -
Dec. 31, 2025 15000 676000 1.3 million -
Sept. 30, 2025 22000 1.0 million 888000 -
June 30, 2025 - 1.1 million 1.3 million -

ERNAW Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 86000
Dec. 31, 2025 - 69000
Sept. 30, 2025 - 70000
June 30, 2025 - 55000

ERNAW

Price: $0.05

52 week price:
0.02
0.23

Exchange: NGM

Sector: Financial Services

Industry: Asset Management

Market Capitalization: 343180

Links: